Efficacy and Safety of Intracochlear Injection of Glucocorticoid Through the Round Window Membrane in Patients With Profound or Complete Sudden Sensorineural Hearing Loss
Condition(s) studied
Investigational drug(s) / intervention(s)
intracochlear injection of triamcinolone acetonide through the round window membrane: intracochlear injection of triamcinolone acetonide through the round window membrane
intratympanic dexamethasone injection through the tympanic membrane: intratympanic dexamethasone injection through the tympanic membrane
Study summary
Safety and efficacy of intracochlear injection of glucocorticoid through the round window membrane in patients with profound or complete sudden sensorineural hearing loss
Eligibility
Primary outcome measure(s)
- Change from Baseline in pure tone audiometry (PTA) — Baseline , Week2 , Week4, Week12, Week24.
hearing capacity of thresholds ( PTA) - Change from Baseline in Speech Discrimination Scores — Baseline , Week4, Week12, Week24.
hearing capacity of thresholds ( speech discrimination )
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Eye and ENT Hospital, Fudan University | Shanghai | Shanghai Municipality |
More Eye & ENT Hospital of Fudan University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07814677 on ClinicalTrials.gov ↗ ← All trials in China